Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2100 participants.
Also called NCT07190690
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,100 participants
- Sponsor
- Registry
-
NCT07190690
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07190690. Randomized; no masking; primary purpose treatment. Start 2025-12-19 (actual); primary completion 2029-10-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
- Acronym
- DestinACSion
- Condition
- Coronary Artery Disease
- Intervention (Device)
- ihtDEStiny® DES implanted
- Intervention (Device)
- Xience™ DES implanted
- Lead sponsor
- Fundación EPIC
Record details
- Record id
cardio:ct-nct07190690- Content hash
21e660aae68d0e2ab1c090d5f33b81ac79b59d9d077798633695b11257f456ac